Trial Search Results

Radiofrequency-Guided Localization in Patients With Abnormal Breast Tissue Undergoing Lumpectomy

This pilot clinical trial studies the use of the radiofrequency-guided localization in patients with abnormal breast tissue undergoing lumpectomy (a type of breast-sparing surgery). The radiofrequency identification localization system consists of an implantable radiofrequency identification tag and a hand-held radiofrequency reader to mark abnormal breast tissue before surgery and later surgically retrieve them. Radiofrequency-guided localization may make it easier to find and remove abnormal breast tissue during lumpectomy.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Cancer Institute (NCI)

Stanford Investigator(s):

Intervention(s):

  • Procedure: Lumpectomy
  • Other: Questionnaire Administration
  • Procedure: Radiofrequency-Guided Localization

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Have had stereotactic or ultrasound-guided biopsy with marker placement

   - Have a lesion or biopsy marker that is visible under ultrasound

   - Have a surgical target =< 6 cm from the skin when lying supine

   - Have a discreet surgical target

   - Have a lesion in which the center/focal area is defined

   - Have the ability to understand and the willingness to sign a written informed consent
   document

   - Eastern Cooperative Oncology Group (ECOG)/Karnofsky performance status will not be
   used as an inclusion criterion

   - Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

   - Require more than one localization needle for localization of the surgical target
   (bracket localization)

   - Have undergone previous open surgical biopsy, lumpectomy, or mastectomy in the
   operative breast

   - Have a prosthesis/implant in the operative breast

   - Have a cardiac pacemaker or defibrillator device

   - Be contraindicated for surgery

   - Be pregnant

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Sumita Sood
650-723-0186
Not Recruiting